Related Experiment Video
Updated: May 13, 2025

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
Published on: May 10, 2015
Deubiquitinase USP24 activated by IL-6/STAT3 enhances PD-1 protein stability and suppresses T cell antitumor response
Hung-Chia Hsieh1, Ming-Jer Young2, Kuan-Yu Chen3
1Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
Abstract:
Persisting programmed cell death-1 (PD-1) signaling impairs T cell effector function, which is highly associated with T cell exhaustion and immunotherapy failure. However, the mechanism responsible for PD-1 deubiquitination and T cell dysfunction remains unclear. Here, we show that ubiquitin-specific peptidase 24 (USP24) promotes PD-1 protein stability by removing K48-linked polyubiquitin. Increased interleukin-6 level transcriptionally activates the USP24 expression, which leads to PD-1 stabilization. Furthermore, USP24 deficiency reduces PD-1 levels in CD8+ T cells and attenuates Egfr-driven lung tumorigenesis in Usp24 catalytic deficient mice. Targeting PD-1 stability with the USP24-specific inhibitor USP24-i-101 boosts cytotoxic T cell activity, restrains lung tumor growth, and achieves superior therapeutic effects when combined with anti-CTLA4 immunotherapy. Clinically, patients with lung cancer exhibiting high USP24 expression in tumor-infiltrating CD8+ T cells display exhausted features and show unfavorable responses to immunotherapy. Our findings dissect the mechanism for regulating enhanced PD-1 stability in tumor-infiltrating CD8+ T cells and reveal USP24 as a potential target of antitumor immunotherapy.
Insights
Ubiquitin-specific peptidase 24 (USP24) stabilizes programmed cell death-1 (PD-1) in T cells, driving exhaustion and immunotherapy failure. Inhibiting USP24 restores T cell function and enhances cancer treatment efficacy.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Persistent programmed cell death-1 (PD-1) signaling contributes to T cell exhaustion and immunotherapy resistance.
- The precise mechanisms regulating PD-1 deubiquitination and subsequent T cell dysfunction are not fully understood.
Purpose of the Study:
- To elucidate the role of ubiquitin-specific peptidase 24 (USP24) in PD-1 protein stability and T cell function.
- To investigate USP24 as a potential therapeutic target for enhancing cancer immunotherapy.
Main Methods:
- Investigated the deubiquitinating activity of USP24 on PD-1 using biochemical assays.
- Utilized cell-based assays and genetically modified mouse models (including catalytic-deficient mice) to study USP24 function in T cells and lung tumorigenesis.
- Administered USP24-specific inhibitors and combination immunotherapies (anti-CTLA4) in preclinical models.
- Analyzed clinical samples from lung cancer patients to correlate USP24 expression with T cell exhaustion and immunotherapy response.
Main Results:
- USP24 deubiquitinates PD-1 by removing K48-linked polyubiquitin, thereby stabilizing the PD-1 protein.
- Interleukin-6 (IL-6) upregulates USP24 expression, leading to increased PD-1 stability.
- USP24 deficiency in mice reduced PD-1 levels in CD8+ T cells and attenuated EGFR-driven lung tumorigenesis.
- A USP24-specific inhibitor (USP24-i-101) enhanced cytotoxic T cell activity, suppressed tumor growth, and improved outcomes when combined with anti-CTLA4 therapy.
- High USP24 expression in tumor-infiltrating CD8+ T cells from lung cancer patients correlated with T cell exhaustion and poor immunotherapy response.
Conclusions:
- USP24 plays a critical role in maintaining PD-1 stability within tumor-infiltrating CD8+ T cells.
- USP24 represents a novel therapeutic target for overcoming T cell exhaustion and improving the efficacy of cancer immunotherapy, particularly in lung cancer.
Related Concept Videos
Abnormal Proliferation
The JAK-STAT Signaling Pathway
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
PI3K/mTOR/AKT Signaling Pathway
Regulation of the Unfolded Protein Response

